2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
55
Unknown
31
Recruiting
19
Terminated
8
Not yet recruiting
5
Withdrawn
4
Active not recruiting
3
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Neoplasms
47
Breast Neoplasms
47
Colorectal Neoplasms
28
Prostatic Neoplasms
27
Carcinoma, Non-Small-Cell Lung
21
Leukemia, Myeloid, Acute
19
Glioblastoma
19
Pancreatic Neoplasms
17
Melanoma
17
Lung Neoplasms
17
Neoplasm Metastasis
16
Glioma
14
Stomach Neoplasms
13
Ovarian Neoplasms
13
Carcinoma, Hepatocellular
13
Brain Neoplasms
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Triple Negative Breast Neoplasms
10
Myelodysplastic Syndromes
10
Multiple Myeloma
10
Head and Neck Neoplasms
10
Carcinoma, Renal Cell
10
Lymphoma
9
Uterine Cervical Neoplasms
7
Sarcoma
7
Rectal Neoplasms
7
Leukemia
7
Hematologic Neoplasms
7
Esophageal Neoplasms
7
Colonic Neoplasms
7
Interventions
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Drug-Related Side Effects and Adverse Reactions
×
Clear all
NCT04824352
2024-05-14
AIEO
Peking University People's Hospital
Phase 2
Suspended
44 enrolled